심혈관 및 대사 모니터링용 의료용 웨어러블 시장 예측(-2034년) : 디바이스 유형, 모니터링 기능, 접속성 및 기술, 유통 채널, 최종사용자 및 지역별 분석

According to Stratistics MRC, the Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market is accounted for $58.8 billion in 2026 and is expected to reach $230.3 billion by 2034 growing at a CAGR of 18.6% during the forecast period. Wearable medical technologies for cardiovascular and metabolic monitoring provide continuous access to important health information, supporting proactive and personalized healthcare. Devices such as smartwatches, sensor patches, and wearable bands can track parameters including heart rate, blood pressure, oxygen levels, glucose, movement, and other physiological measures. Their expanding use facilitates remote monitoring, identification of potential health changes, preventive interventions, and individualized treatment management. Developments in biosensing technologies, compact electronics, wireless communication, and artificial intelligence are enhancing device accuracy, functionality, comfort, and connectivity with modern healthcare platforms.

According to the World Health Organization (WHO), cardiovascular diseases cause an estimated 17.9 million deaths globally each year, making cardiovascular disease the leading cause of death worldwide. This supports the need for continuous cardiovascular monitoring and creates a substantial underlying demand for wearable monitoring technologies.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular and metabolic diseases

The growing burden of cardiovascular and metabolic conditions is increasing the need for wearable medical technologies capable of continuous health tracking. Patients affected by diabetes, hypertension, obesity, and heart-related disorders often require frequent observation of important physiological measures. Wearables offer convenient ways to track heart rate, blood pressure, glucose, physical activity, and related indicators beyond hospitals and clinics. Greater focus on preventive medicine, early identification of health changes, remote monitoring, and individualized care is supporting broader adoption of these devices among patients and healthcare professionals.

Restraint:

High cost of advanced wearable devices

Expensive advanced wearable technologies can limit their broader adoption among cost-conscious users and healthcare organizations operating under restricted budgets. Wearables equipped with sophisticated sensors, continuous tracking functions, wireless connectivity, and artificial intelligence generally involve higher costs than traditional monitoring approaches. Expenses associated with subscriptions, maintenance, calibration, and digital services can add to ownership costs over time. Furthermore, insufficient reimbursement for some wearable monitoring applications can create financial barriers, particularly in emerging healthcare systems and among patients with limited ability to pay.

Opportunity:

Integration with remote patient monitoring

Connecting medical wearables with remote patient monitoring platforms creates new growth opportunities for cardiovascular and metabolic health management. These devices can continuously capture physiological information and securely share measurements with healthcare professionals outside conventional medical settings. Such capabilities can assist in monitoring individuals with diabetes, hypertension, cardiovascular disorders, and other chronic conditions while potentially reducing routine clinic visits. Integration with telemedicine services, electronic health records, and digital healthcare platforms can strengthen information exchange, support earlier clinical responses, improve continuity of care, and broaden access to remote monitoring solutions.

Threat:

Rapid technological obsolescence and competitive innovation

Fast-paced technological progress can challenge the medical wearables market as cardiovascular and metabolic monitoring devices may lose relevance when improved sensors, software, connectivity technologies, and analytical capabilities become available. Companies need continuous investment in research, product development, upgrades, and innovation to maintain competitiveness. Frequent technology changes can raise development expenses while encouraging users and healthcare organizations to replace older devices. Competition from established medical technology manufacturers, technology companies, and startups can additionally intensify pricing pressures and make product differentiation more difficult.

Covid-19 Impact:

COVID-19 increased adoption interest in cardiovascular and metabolic monitoring wearables as healthcare systems sought remote approaches to patient management. Connected wearable devices helped support monitoring beyond clinical facilities, while individuals increasingly used wearable technologies to observe health indicators and physical activity. The disruption of routine healthcare services demonstrated the potential importance of continuous monitoring for chronic disease management. At the same time, manufacturing shutdowns, supply-chain disruptions, postponed medical procedures, clinical research delays, and changing healthcare investment priorities created temporary challenges for the wearable technology market.

The smartwatches with health monitoring segment is expected to be the largest during the forecast period

The smartwatches with health monitoring segment is expected to account for the largest market share during the forecast period. Their widespread use stems from combining healthcare monitoring functions with convenient everyday digital features. Wrist-worn devices can track heart rate, blood oxygen, physical activity, sleep patterns, and various other physiological measurements. Easy smartphone integration, user-friendly interfaces, compact designs, and increasingly sophisticated sensors enhance their practicality for routine health tracking. These capabilities also facilitate personalized wellness management and remote observation, making smartwatches useful across a broad range of users and applications.

The home healthcare users segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare users segment is predicted to witness the highest growth rate. Expansion is being encouraged by rising preference for home-based care, remote monitoring, and continuous management of chronic cardiovascular and metabolic diseases. Wearable technologies enable individuals to monitor important health parameters from home while allowing clinicians to access relevant information remotely. Increasing emphasis on convenient healthcare delivery, fewer hospital visits, connected patient management, and personalized monitoring is creating stronger demand for wearable solutions among home-based healthcare users.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by broad acceptance of sophisticated healthcare technologies and connected wearable devices. Its developed healthcare infrastructure, awareness of preventive monitoring, and established wearable ecosystem encourage market adoption. The integration of wearable-generated information with digital healthcare platforms, remote monitoring solutions, and clinical workflows is creating additional demand. Rising consumer preference for continuous measurement of cardiovascular and metabolic health indicators is also contributing to the region's strong market position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Regional expansion is being encouraged by developing healthcare systems, greater use of digital healthcare technologies, and growing awareness of continuous health tracking. Rising cardiovascular and metabolic disease prevalence is increasing interest in convenient wearable monitoring solutions. Wider smartphone usage, better connectivity, remote healthcare services, and digital transformation are strengthening adoption. Increasing availability of wearable technologies across emerging countries is additionally creating favorable conditions for continued regional market expansion throughout the forecast period.

Key players in the market

Some of the key players in Medical Wearables for Cardiovascular & Metabolic Monitoring Market include Adaptyx Biosciences, Apple Inc., Abbott Laboratories, Medtronic plc, iRhythm Technologies, Inc., Boston Scientific Corporation, Koninklijke Philips N.V., Biolinq, DexCom, Inc., Nanowear, Ultrahuman, VitalConnect, AliveCor, Inc., Samsung Electronics Co., Ltd., Fitbit LLC, Wearlinq, Glucotrack, Inc. and Masimo Corporation.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Device Types Covered:

• Smartwatches with Health Monitoring
• Fitness Bands & Activity Trackers
• Chest Straps & Patches
• Implantable Wearables
• Smart Clothing

Monitoring Functions Covered:

• Cardiovascular Monitoring
• Metabolic Monitoring
• Combined Cardiovascular & Metabolic Monitoring

Connectivity & Technologies Covered:

• Bluetooth-enabled Wearables
• Wi-Fi & Cloud-connected Devices
• AI-driven Predictive Analytics Wearables
• Continuous Remote Monitoring Platforms

Distribution Channels Covered:

• Online Platforms
• Offline Retail

End Users Covered:

• Hospitals & Clinics
• Ambulatory Care Centers
• Home Healthcare Users
• Fitness & Wellness Consumers
• Research Institutions

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market, By Device Type

• 5.1 Smartwatches with Health Monitoring
• 5.2 Fitness Bands & Activity Trackers
• 5.3 Chest Straps & Patches
• 5.4 Implantable Wearables
• 5.5 Smart Clothing

6 Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market, By Monitoring Function

• 6.1 Cardiovascular Monitoring
• 6.2 Metabolic Monitoring
• 6.3 Combined Cardiovascular & Metabolic Monitoring

7 Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market, By Connectivity & Technology

• 7.1 Bluetooth-enabled Wearables
• 7.2 Wi-Fi & Cloud-connected Devices
• 7.3 AI-driven Predictive Analytics Wearables
• 7.4 Continuous Remote Monitoring Platforms

8 Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market, By Distribution Channel

• 8.1 Online Platforms
• 8.2 Offline Retail

9 Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market, By End User

• 9.1 Hospitals & Clinics
• 9.2 Ambulatory Care Centers
• 9.3 Home Healthcare Users
• 9.4 Fitness & Wellness Consumers
• 9.5 Research Institutions

10 Global Medical Wearables for Cardiovascular & Metabolic Monitoring Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Adaptyx Biosciences
• 13.2 Apple Inc.
• 13.3 Abbott Laboratories
• 13.4 Medtronic plc
• 13.5 iRhythm Technologies, Inc.
• 13.6 Boston Scientific Corporation
• 13.7 Koninklijke Philips N.V.
• 13.8 Biolinq
• 13.9 DexCom, Inc.
• 13.10 Nanowear
• 13.11 Ultrahuman
• 13.12 VitalConnect
• 13.13 AliveCor, Inc.
• 13.14 Samsung Electronics Co., Ltd.
• 13.15 Fitbit LLC
• 13.16 Wearlinq
• 13.17 Glucotrack, Inc.
• 13.18 Masimo Corporation